Tim focuses on the sociology of health using qualitative methods.
His work concentrates on the social relations of access to care, especially in relation to drug use, addictions, HIV and hepatitis C.
His recent and current qualitative research explores the implementation of harm reduction and health care interventions among people who inject drugs, and qualitative longitudinal research exploring how illness is 'made long' in conditions of precarity (focusing on Long Covid).
Informed by science and technology studies, he is undertaking various work in the social study of science and evidence-making, including in the fields of outbreaks, early warning, mathematical modelling, overdose, Covid-19, and hepatitis C.
He also holds a part-time appointment as Professor of the Sociology of Health at the University of New South Wales (Australia).
His work concentrates on the social relations of access to care, especially in relation to drug use, addictions, HIV and hepatitis C.
His recent and current qualitative research explores the implementation of harm reduction and health care interventions among people who inject drugs, and qualitative longitudinal research exploring how illness is 'made long' in conditions of precarity (focusing on Long Covid).
Informed by science and technology studies, he is undertaking various work in the social study of science and evidence-making, including in the fields of outbreaks, early warning, mathematical modelling, overdose, Covid-19, and hepatitis C.
He also holds a part-time appointment as Professor of the Sociology of Health at the University of New South Wales (Australia).
Affiliations
Department of Public Health, Environments and Society
Faculty of Public Health and Policy
Centres
Centre for Evaluation
Centre for Maternal Adolescent Reproductive & Child Health
Teaching
PhD supervision in sociological studies of health practices using qualitative methods; MSc course lead and/or co-lead and lecturing on Qualitative Methodologies (since 2008); MSc co-lead on Sociological Approaches in Health (2023-2024); MSc lecturing on qualitative methods, the sociology of risk, health and evidencing-making, and the sociology of drug use; currently developing a short course on qualitative methods in health research.
Research
Recent and current projects include:
1 Qualitative research on the 'evidence-making' of 'outbreak science', including the use of modelling in viral elimination and disease control (Covid-19 and hepatitis C) and 'early warning' in relation to overdose and drug outbreak;
2 Qualitative longitudinal research on 'illness made long' in precarity among young people affected by Long Covid (UK);
3 Qualitative longitudinal research on the social effects of Covid-19, including Long Covid, among adults (Australia);
4 Qualitative collaborative research on health care worker responses to Covid-19 (Colombia and Australia); and
5 Qualitative research on the health and livelihood effects of illicit drug economies in war to peacetime transitions in Myanmar and Colombia.
1 Qualitative research on the 'evidence-making' of 'outbreak science', including the use of modelling in viral elimination and disease control (Covid-19 and hepatitis C) and 'early warning' in relation to overdose and drug outbreak;
2 Qualitative longitudinal research on 'illness made long' in precarity among young people affected by Long Covid (UK);
3 Qualitative longitudinal research on the social effects of Covid-19, including Long Covid, among adults (Australia);
4 Qualitative collaborative research on health care worker responses to Covid-19 (Colombia and Australia); and
5 Qualitative research on the health and livelihood effects of illicit drug economies in war to peacetime transitions in Myanmar and Colombia.
Selected Publications
2024
BMJ global health
2024
Social science & medicine (1982)
2023
The International journal on drug policy
2023
International Journal of Drug Policy
2022
Medical anthropology
2022
Sociology of Health & Illness
2022
Social Science & Medicine
2021
Sociology of health & illness
2020
The International journal on drug policy
2020
BMJ GLOBAL HEALTH
